Reply to: Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
J Clin Oncol
.
2025 Jan 6:JCO2402435.
doi: 10.1200/JCO-24-02435.
Online ahead of print.
Authors
Aaron J Scott
1
,
Erin B Kennedy
1
,
Sepideh Gholami
1
Affiliation
1
Aaron J. Scott, MD, University of Arizona Cancer Center, Tucson, AZ; Erin B. Kennedy, MHSc, American Society of Clinical Oncology, Alexandria, VA; and Sepideh Gholami, MD, MAS, Northwell Health, New Hyde Park, NY.
PMID:
39761507
DOI:
10.1200/JCO-24-02435
No abstract available